Position in TLRY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$162,519
New position
Shares Held
25,119
first reported quarter
Ownership
0.022%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Mariner, LLC holds $80,494,778 across 23 Drug Manufacturers - Specialty & Generic names. TLRY ranks #17 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
160,869 | $21,192,881 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
27,937 | $16,566,080 | |
| 3 | ZTS |
Zoetis Inc.
|
117,842 | $13,930,101 | |
| 4 | HLN |
Haleon plc
|
636,787 | $6,374,236 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
234,988 | $4,351,976 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
131,941 | $3,974,062 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
315,554 | $3,922,336 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
221,274 | $3,064,644 |
All Filings in TLRY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $162,519 | 25,119 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||